Hire an Advanced Robo-Advisor to Trade ABT on Your Behalf.
- Street Sentiment
- Personalized Strategy
- Free Trading Simulator
Course of Action
Sentiment (10 days)
- Strong Buy
- Strong Sell
DAILY PRICE CHANGE VS SENTIMENT
Why Smart Auto-Trading?
Smart Auto-Trading is an advanced Robo-Trader designed to automate systematic stock investing. Its robo is designed to screens, monitors and auto-trades elite stocks like ABBOTT LABORATORIES (ABT) using Artificial Intelligence signals. It is designed to augment your profit potential.
Smart Auto-Trading produces short-term trades which makes it an ideal tool for trading in tax-deferred accounts such as IRA, SIMPLE IRA, Rollover IRA, 529 College Plans, Keoghs and UGMAs. If also works in taxable accounts. Just be aware that if you elect to auto-trade using Smart Auto-Trading in a regular brokerage account, you will be taxed at regular income. Make sure you understand your tax situation before using Smart Auto-trading.
Using Smart Auto-Trading is easy. It connects to your brokerage account at Ally Invest. Ally Invest is one of the most trusted broker/dealer in the United States. All you need to do is open an account with them, put a minimum of $25,000 in your account and connect Smart Auto-Trading to auto-trade.
There are clear benefits associated with using a robo-Trader such as Smart Auto-Trading to help you reach your financial goals. Smart Auto-Trading simplifies stock investing down to a few steps. It auto-trades for you, using your personalized strategy, while you attend more important life events.
Using Smart Auto-Trading is like having thousands of traders working for you to help you reach your financial goals.
Smart Auto-Trading actively trades the S&P 500 on your behalf. Its Artificial Intelligence is on the lookout, working to maximize your potential every business day of the year. It 'trades on the news' taking advantage of price changes and trends by listening to trader's communications and by validating this information with market data.
Smart Auto-Trading is one of the first robo-Trader to take advantage of Government grade listening technology, Artificial Intelligence, social media and market data natively.
Try Smart Auto-Trading today!
You can test Smart Auto-Trading in simulation mode, risk free, Stock Circles today.
Disclaimer: Past performance may not be indicative of future results. Therefore, you should assume that the future performance of any specific investment, investment strategy (including robo-strategies), or product made in reference directly or indirectly on this website, will be profitable or equal to corresponding indicated performance levels. Robot-Traders like other investment methods rely on favorable market conditions to provide positive outcomes.
ABBOTT LABORATORIES (ABT) News
Abbott Laboratories (NYSE:ABT) Updates FY18 Earnings Guidance
Aug 3rd, 2018 - Abbott Laboratories (NYSE:ABT) updated its FY18 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $2.85-2.91 for the period, compared to the Thomson Reuters consensus estimate of $2.86. Abbott Laboratories also updated its Q3 guidance to $0.73-0.75 EPS.
A number of research analysts have weighed in on the company. Zacks Investment Research lowered Abbott Laboratories from a buy rating to a hold rating in a research note on Tuesday. Stifel Nicolaus increased their target price on Abbott Laboratories from $71.00 to $72.00 and gave the stock a buy rating in a research report on Thursday, July 19th. Royal Bank of Canada reaffirmed a buy rating and issued a $70.00 target price on shares of Abbott Laboratories in a research report on Thursday, July 19th. Sanford C. Bernstein initiated coverage on Abbott Laboratories in a research report on Wednesday, June 27th. They issued an outperform rating and a $73.00 target price on the stock. Finally, BTIG Research reaffirmed a hold rating on shares of Abbott Laboratories in a research report on Sunday, April 22nd. Five research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. The company presently has a consensus rating of Buy and an average price target of $69.76.Get Started today! - Risk Free